Home › Companies › LIGAND PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and LIGAND PHARMACEUTICALS INC.’s Form 8-K, filed June 17, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 14, 2024: 11 items on LIGAND PHARMACEUTICALS INC.’s Form 8-K, filed June 17, 2024: 8 elected · 3 approved.
Significant dissent: 1 director (21.0% against).
Notable dissent: 1 other board item (36.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore LIGAND PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LIGAND PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jason M. Aryeh | 12,265,786 | -- | -- | 3,259,850 | 1,154,516 | 79% | Elected | — |
| Elect Director: Todd C. Davis | 15,244,447 | -- | -- | 281,189 | 1,154,516 | 98% | Elected | — |
| Elect Director: Nancy R. Gray, Ph.D. | 14,876,443 | -- | -- | 649,193 | 1,154,516 | 96% | Elected | — |
| Elect Director: Jason Haas | 15,284,373 | -- | -- | 241,263 | 1,154,516 | 98% | Elected | — |
| Elect Director: John W. Kozarich, Ph.D. | 14,024,170 | -- | -- | 1,501,466 | 1,154,516 | 90% | Elected | — |
| Elect Director: John L. LaMattina, Ph.D. | 14,981,023 | -- | -- | 544,613 | 1,154,516 | 96% | Elected | — |
| Elect Director: Stephen L. Sabba, M.D. | 14,839,776 | -- | -- | 685,860 | 1,154,516 | 96% | Elected | — |
| Elect Director: Martine Zimmermann, Pharm.D. | 15,067,611 | -- | -- | 458,025 | 1,154,516 | 97% | Elected | — |
| 2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 15,908,245 | 754,285 | 17,622 | -- | -- | 95% | Approved | — |
| 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers | 14,264,205 | 1,253,085 | 8,346 | -- | 1,154,516 | 92% | Approved | — |
| 4. The approval of the Restated Plan | 9,926,628 | 5,577,590 | 21,418 | -- | 1,154,516 | 64% | Approved | — |
Source: LIGAND PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 17, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
300 asset managers disclosed a vote on at least one LIGAND PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LIGAND PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 95.4% for (June 9, 2023 meeting) ▲ 3.0 pts
Description as filed by funds: Election of Directors: Jason Haas
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jason Haas”): 15,284,373 for, 241,263 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,494,058 for, 1,509 withheld, 1,150 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,297 | 0 | 0 | 49 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Prior year: 56.5% for (June 9, 2023 meeting) ▲ 22.5 pts
Description as filed by funds: Election of Directors: Jason M. Aryeh
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jason M. Aryeh”): 12,265,786 for, 3,259,850 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 7,821,461 for, 1,673,740 withheld, 1,516 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 737,642 | Withhold |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 514 | 0 | 0 | 286,832 | Withhold |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 0 | 255,208 | Withhold |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 107,525 | Withhold |
| Aberdeen | 0 | 0 | 0 | 104,221 | Withhold |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 10,031 | 0 | 0 | 56,456 | Mixed |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 42,665 | Withhold |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 94.8% for (June 9, 2023 meeting) ▲ 1.6 pts
Description as filed by funds: Election of Directors: John L. LaMattina, Ph.D.
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John L. LaMattina, Ph.D.”): 14,981,023 for, 544,613 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,493,169 for, 2,143 withheld, 1,405 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,273 | 0 | 0 | 73 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 70.4% for (June 9, 2023 meeting) ▲ 20.0 pts
Description as filed by funds: Election of Directors: John W. Kozarich, Ph.D.
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John W. Kozarich, Ph.D.”): 14,024,170 for, 1,501,466 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,099,749 for, 395,563 withheld, 1,405 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,234 | 0 | 0 | 112 | For |
| IMPAX FUNDS SERIES TRUST I | 0 | 0 | 0 | 255,208 | Withhold |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 104,221 | Withhold |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Martine Zimmermann, Pharm.D.
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Martine Zimmermann, Pharm.D.”): 15,067,611 for, 458,025 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,470,183 for, 19,717 withheld, 1,150 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,346 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 95.2% for (June 9, 2023 meeting) ▲ 0.6 pts
Description as filed by funds: Election of Directors: Nancy R. Gray, Ph.D.
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nancy R. Gray, Ph.D.”): 14,876,443 for, 649,193 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,471,835 for, 23,477 withheld, 1,405 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,257 | 0 | 0 | 89 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 94.4% for (June 9, 2023 meeting) ▲ 1.1 pts
Description as filed by funds: Election of Directors: Stephen L. Sabba, M.D..
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Stephen L. Sabba, M.D.”): 14,839,776 for, 685,860 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,471,880 for, 23,432 withheld, 1,405 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,273 | 0 | 0 | 73 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 25,727 | 0 | 0 | 21,289 | Mixed |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.4% for (June 9, 2023 meeting) ▲ 0.8 pts
Description as filed by funds: Election of Directors: Todd C. Davis
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Todd C. Davis”): 15,244,447 for, 281,189 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “In accordance with the results below, each nominee was elected to serve as a director of the Company.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 90 asset managers below reported 9,493,348 for, 1,964 withheld, 1,405 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,273 | 0 | 0 | 73 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,695 | 0 | 255 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
66% of fund votes cast · no official result
The 96 asset managers below reported 6,270,582 for, 3,204,714 against, 15,443 abstained, 346 unknown. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,940,794 | 325,961 | 0 | 0 | Mixed |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 737,642 | 0 | 0 | Against |
| Dimensional | 0 | 562,595 | 0 | 0 | Against |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 243 | 287,103 | 0 | 0 | Against |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 0 | 230,218 | 0 | 0 | Against |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 104,221 | 0 | 0 | Against |
| Invesco | 0 | 103,295 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 98,553 | 0 | 0 | Against |
| Bridge Builder Trust | 6,397 | 87,553 | 0 | 0 | Mixed |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 66,487 | 0 | 0 | Against |
| Allspring | 0 | 66,485 | 0 | 0 | Against |
| WILLIAM BLAIR FUNDS | 0 | 60,340 | 0 | 0 | Against |
| Equitable | 25,727 | 21,289 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 0 | 45,194 | 0 | 0 | Against |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 0 | 39,282 | 0 | 0 | Against |
Showing the 25 largest of 96 asset managers. All 96 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 87.9% for (June 9, 2023 meeting) ▲ 4.0 pts
Description as filed by funds: Approval, on an advisory basis, of the compensation of the named executive officers
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers”): 14,264,205 for, 1,253,085 against — passed, per its Form 8-K filed June 17, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “In accordance with the results below, the proposal was approved.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,257 | 89 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 104,221 | 0 | 0 | Against |
| Invesco | 0 | 103,295 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 98,553 | 0 | 0 | Against |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Fund voting reports, all 94 managers: 9,140,585 for, 377,995 against, 1,460 abstained, 346 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 975,601 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 883,700 | 0 | 0 | 0 | For |
| State Street | 611,650 | 249 | 0 | 0 | For |
| CONGRESS ASSET MANAGEMENT CO /MA | 514,433 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 508,005 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 468,510 | 0 | 0 | Against |
| BlackRock | 416,396 | 5,101 | 0 | 0 | For |
| VILLERE ST DENIS J & CO LLC | 417,364 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 356,671 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 264,396 | 0 | 0 | Against |
| ASHFORD CAPITAL MANAGEMENT INC | 226,285 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 3,402 | 218,605 | 0 | 0 | Against |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 218,421 | 0 | 0 | 0 | For |
| Northern Trust | 160,193 | 11 | 0 | 0 | For |
| Charles Schwab | 151,806 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 140,831 | 0 | 0 | 0 | For |
| SEI | 127,922 | 11,667 | 0 | 0 | Mixed |
| Chicago Capital, LLC | 138,233 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 118,143 | 0 | 0 | 0 | For |
| Invesco | 0 | 109,538 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 89,526 | 0 | 0 | 0 | For |
| Knott David M Jr | 75,000 | 0 | 0 | 0 | For |
| Allspring | 73,991 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 68,355 | 0 | 0 | Against |
| ENVESTNET ASSET MANAGEMENT INC | 65,922 | 0 | 0 | 0 | For |
Institutional-manager reports, all 232 managers: 7,529,541 for, 1,351,577 against, 284 abstained, 385 not voted, 1,448 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 97.8% for (June 9, 2023 meeting) ▼ 2.3 pts
Description as filed by funds: Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 15,908,245 for, 754,285 against — passed, per its Form 8-K filed June 17, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “In accordance with the results below, the selection of Ernst & Young LLP was ratified.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 95 asset managers below reported 9,490,329 for, 11,340 against, 1,460 abstained, 346 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,266,755 | 0 | 0 | 0 | For |
| BlackRock | 1,643,577 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 912,488 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 737,642 | 0 | 0 | 0 | For |
| Dimensional | 562,595 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 425,658 | 0 | 0 | 0 | For |
| Fidelity | 341,093 | 0 | 0 | 0 | For |
| State Street | 287,323 | 23 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 255,208 | 0 | 0 | 0 | For |
| DWS | 230,218 | 0 | 0 | 0 | For |
| Charles Schwab | 143,215 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| SEI | 107,525 | 0 | 0 | 0 | For |
| Aberdeen | 104,221 | 0 | 0 | 0 | For |
| Invesco | 103,295 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 98,553 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 93,950 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 70,694 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,487 | 0 | 0 | 0 | For |
| Allspring | 66,485 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 60,340 | 0 | 0 | 0 | For |
| Equitable | 47,016 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 45,194 | 0 | 0 | 0 | For |
| TIAA | 42,665 | 0 | 0 | 0 | For |
| Jackson National | 39,282 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 17,924,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.65% |
| 2 | BlackRock | 9.17% |
| 3 | JANUS INVESTMENT FUND | 5.09% |
| 4 | Delaware/Macquarie | 4.12% |
| 5 | Dimensional | 3.14% |
| 6 | PROFESSIONALLY MANAGED PORTFOLIOS | 2.37% |
| 7 | Fidelity | 1.90% |
| 8 | State Street | 1.60% |
| 9 | IMPAX FUNDS SERIES TRUST I | 1.42% |
| 10 | DWS | 1.28% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 5.44% |
| 2 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 4.93% |
| 3 | State Street | 3.41% |
| 4 | CONGRESS ASSET MANAGEMENT CO /MA | 2.87% |
| 5 | Stephens Investment Management Group LLC | 2.83% |
| 6 | Man Group plc | 2.61% |
| 7 | BlackRock | 2.35% |
| 8 | VILLERE ST DENIS J & CO LLC | 2.33% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.99% |
| 10 | Aberdeen | 1.48% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 2,884,527 | 16.09% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 2,076,283 | 11.58% | Form 13F, quarter ended March 31, 2024 |
| Janus Henderson Group plc | 1,343,154 | 7.49% | Proxy statement (DEF 14A), table as of April 19, 2024 |
| Macquarie Group Limited | 987,248 | 5.51% | Proxy statement (DEF 14A), table as of April 19, 2024 |
| State Street | 671,284 | 3.75% | Form 13F, quarter ended March 31, 2024 |
| Dimensional Fund Advisors | 664,081 | 3.70% | Form 13F, quarter ended March 31, 2024 |
| FMR (Fidelity) | 457,231 | 2.55% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 380,970 | 2.13% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 367,795 | 2.05% | Form 13F, quarter ended March 31, 2024 |
| Matthew Korenberg | 243,941 | 1.36% | Proxy statement (DEF 14A), table as of April 19, 2024 |
Percentages above are of 17,924,000 shares outstanding, as reported by LIGAND PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At LIGAND PHARMACEUTICALS INC.'s shareholder meeting held June 14, 2024, in the 2023-2024 proxy season, 300 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 3,631 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the named executive officers — LIGAND PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: LIGAND PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LIGAND PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
LIGAND PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “LIGAND PHARMACEUTICALS (LGND) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ligand-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.